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cause (lack of VF re-inltlatlon) for the defibdtiat;on th,ashold (DFT). We 
tested these hypotheses by intsrrugatlng ifBi shocks are less able to induce 
VF ti~n Me shocks. Ten isolated Langendo~.perfused rabbft hearts were 
Immersed In a tank flanked by shock electrodes and paced at 500 ms cycle 
lergth. Me and Bi T wave shocks of 5 ms overall duration were applied at 
ratrdomly varied shock strengths and coupling intervals (CI) to determine 
the two~imanslonef "area of vulnerability" (AOV), defined horizontally by 
the shortest and longest VF inducing CI and v¢rUcally by the ULV and the 
lower limit of vulnerability (LLV). The DFT was measured using the delayed 
up-down algorithm. 
Results. A total of 1,576 T wave shoc~ (Me: 788; Bi: 788) ware applied. 
For ai shocks, the ULV was lower (372 4, 62 vs 412 4- 75 V, p = 0.02), the LLV 
higher (228 4- 56 vs 192 4. 38 V, p = 0.04)° and the width of the vulnerable 
period smaller (24.0 4. 13.5 vs 30.0 ± 11.5 ms, p = 0.05), resulting In a 
smaller AOV for BI than for Me shocks (8.9:1:4,2 vs 14.3 4- 6.9 VF inducing 
shocks, p = 0.02). Bi shocks shifted the AOV to longer CI by 12 4. 8 ms (p = 
0,001 ). The DFT was lower for BI shocks (274 .~- 66 vs 353 4- 70V, p < 0.01 )
confirming its higher defibrillation efficacy. 
Conclusions. Bi T wave shocks create a smaller AOV which is shifted 
towat'ds longer C! as compared to Me shocks. These findings suggest that 
Bi shocks exhibit less arrbythmnganeity b  being less able to excite partially 
refractory myocerdium. In keeping with the ULV hypothesis, these findings 
may help explain the different efficacy of Me and Bi defibrillation shocks. 
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F7"~ Unsuccessful Defibrillation: Relnltlation or  
Continuation of  Fibrillation? 
Oscar H. Tovar, Janice L Jones. Georgetown Universi~, Washington, D.C.; 
Department of Veterans Affairs Medical Center, Washington, D.C. 
PRCL ~S~,~ PGL ; Ib 
It remains uncertain whether unsuccessful defibrillating shocks defibrillate 
and reinlttate ven~cular fibrillation (VF) or whether VF continues after the 
shock. We tested the hypothesis that unsuccessful defibrillation occurs when 
insufficient extension of refractoriness in at least one region of the heart allows 
fibrillation to continue. VF (111 episodes, unsuccessful = 50, sucocssful = 
61) was induced in 5 isolated, Langendorff perfusod, rabbit hearts. After 
10 sec VF, defibrillation was attempted through 2 epicardiai patches with 
an 8 ms (55% tilt) monophaslc shock of 0.8.-3,2 A. Action potantlals (AP) 
were recorded with a MAP electrode ptacod in a tow current density region 
between the 2 patches. An ECG was recorded simultaneously. We compared 
mean cycle length (5 cycles) previous to the shock (PRCL), during (SCL) 
and postshcck (PCL) in 13 o~t oi 50 episodes of failed defibrillation for 
which the randomly delivered shock coincided with AP phase 0. Cycle length 
was measured from the beginning of the AP to maximal repolarlzation. 
Defibrillation threshold (leo) was 1.6 A. The number of episodes (n) at each 
current Intensity was: 0.8 A (1), 1.2 A (,1), 1.6 A (3), 2 A (4), 2.4 A (1) PRCL 
(97,4 -4- 2 ms), SCL (96.7 4- 3 ms), and PCL (101 4- 2 ms) were similar (by 
ANOVA, p = NS). 
These results confirm that if the defibrillating shock fails to prolong re- 
fractoriness in at least one low voltage gradient region, previous fibrillation 
wavefronts continue in that region and sustain fibrillation, regardless of shock 
intensity. 
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~ Evaluation of  a • New System for  Transtslephonlc 
interrogation of  Implanlable 
Cardloverter-Oeflbril latom 
Roger A. Winkle, Jonathan J. Langberg, Tom T. Hee, Robert C. Betas(sin, 
Robert G. Hauser on behalf of the Housecall Clinical Investigators. Sequoia 
Hospital, Redwood C i~ CA 
We evaluated a new system for transtelephonic ICD interrogation (Houseoall; 
Ventritex, Inc; Sunnyvale, CA). The receiver is a customized computer. The 
transmitter incorporates atelemetry wand, a status display, and a speaker for 
communicating with the patient, Transmitted ata include real-time measure- 
ments; reel-time and stored electrngrams; detection, therapy, and charge 
history; and programmed IOO settings. Weekly transmissions were sched- 
uled, and patients mode additional transmissions as desired. Accuracy was 
determined by comparing data obtained using Housecell to corresponding 
data from the ICD programmer. Twanty-three patients (66 ± 8 years) were 
enrolled. Transmitters were Io~ted up to 350 miles from receivers, Patients 
had been implanted with Cadence ICDs (52% model V-100, 48% model 
V-110) a mean of 9.1 months before enrollment (range, 1 day to 23.1 me). 
During 4.6 --~ 0.9 weeks, 486 transmissions occurred, which included data 
from 12 spontaneous taohyarrhythmic episodes. All patients were able to 
use the Hotqsecall system, and all data were accurately transmitted. The 
transmitter was operated by the patient in 98.3% of transmissions and by 
a family member in 1.7%. Transtelephonic ICD follow-up could provide a 
means of reducing the incidence of routine and emergency clinic visits, 
more rapidly identifying and characterizing tachyarrhythmic episodes, and 
decreasing patient anxiety. 
9:00 
1-7"39----3-] Syncopes In Patients Wlth Implantsble Cardioverter 
Deflbri l latom 
Die(mar B~nsch, Michael Block, JQrgen Brunn, Max Weber, 
Marco Castrucci, Dirk B0cker, G0nter ereithardt. 
WasffNische-Wi/helms-Unlversity, MOnster, Germany 
Treatment of ventricular lachyarrhythmias with implantable cardioverter de- 
fibrillators does not abolish the risk o~ 3yncopa. However, incidence and risk 
factors of syncope are unknown. This study retrospectively analysed the 
occurrence of syncope in 421 patients with ICDs (follow-up 25 ± 17 months). 
229 patients had recurrent VT and 62 patients suffered syncope. Patian[s 
with low ejection fraction (EF), inducible fast VT (> 200 bpm) or paroxys- 
mal/chronic atrial fibrillation (AF) had a higher risk of syncope than patients 
with high El=, not inducible or with slow VT (< 200 bpm) induced and no 
atrial fibrillation in history. The absence of all three risk factors in 122 patients 
implied a very low dsk of syncope, whereas risk of syncope was high in 123 
patients with at least two risk factors. 
12 24 36 months 
Proportion free of syncope: 90% 85% 80% 
• EF > 40% 93% 88% 88% 
• EF_< 40% 8;~,0 82=/= 7..¢% p = 0.014 
• no VT induced 93% 89% 800 
• slOW VT induced 920 80% 83% 
• fZ.St VTinduced 81% 78% 74% p < 0.011 
• no AF 91% 86% 84% 
• AF 89% 83% 71% n.s. 
• no risk ""~ctor 97% 92% 92% 
• > two risk factors 8,P/= 80% 73% p < 0.002 
The dsk cf syncope is high in ICD-patients within the first year after 
implantation. A iower but still substantial risk to experience first syncope 
remains. Identification of patients with low and high dsk of syncope seems to 
be leasable. Recommendations on restrictions for ICD-patlants hould rather 
be based on individual risk stratification than follow up time alone. 
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~ H l g h  Incidence of  Appropriate ICD Shocks In 
Patients Presenting ~,~dh Syncope 
Mark S, Link, Xenophon Costeas, Caroline Fools, Munther Homoud, 
Hassan Rastegar, N. A. Mark Estes III, Paul J. Wang. New England Medical 
Center, Boston, MA 
In patients with syncope, structural heart disease, and inducible ventficu- 
lar arrhythmias at efectmphysiolngic studies (EPS), ICD implantation is an 
accepted therapy. However data documenting ~,current arrhylhmias in this 
population is scant. We report on 41 such patients with a mean age of 59 
(± 15) years and a mean EF of 35 (:1:14)%. All patients had structural heart 
disease (29 with CAD and 12 with other cardiomyopathlas). At EPS, 30 pa- 
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